References
<A NAME="RS11104ST-1A">1a</A>
Trost BM.
Yeh VSC.
Angew. Chem. Int. Ed.
2002,
41:
861
<A NAME="RS11104ST-1B">1b</A>
Trost BM.
Terrell LR.
J. Am. Chem. Soc.
2003,
125:
338
<A NAME="RS11104ST-1C">1c</A>
Trost BM.
Mino T.
J. Am. Chem. Soc.
2003,
125:
2410
<A NAME="RS11104ST-1D">1d</A>
Trost BM.
Fettes A.
Shireman BT.
J. Am. Chem. Soc.
2004,
126:
2660
Atom economy in organic synthesis:
<A NAME="RS11104ST-2A">2a</A>
Trost BM.
Science
1991,
254:
1471
<A NAME="RS11104ST-2B">2b</A>
Trost BM.
Angew. Chem., Int. Ed. Engl.
1995,
34:
259
<A NAME="RS11104ST-3A">3a</A>
Gaucher A.
Ollivier J.
Salaün J.
Synlett
1991,
151
<A NAME="RS11104ST-3B">3b</A>
Schwindt MA.
Belmont DT.
Carlson M.
Franklin LC.
Hendrickson VS.
Karrick GL.
Poc RW.
Sobicray DM.
Van de Vusse J.
J. Org. Chem.
1996,
61:
9564
<A NAME="RS11104ST-3C">3c</A>
Effenberger F.
Jäger JJ.
J. Org. Chem.
1997,
62:
3867
For reviews on enantioselective synthesis and applications of cyanohydrins:
<A NAME="RS11104ST-4A">4a</A>
Effenberger F.
Angew. Chem., Int. Ed. Engl.
1994,
33:
1555
<A NAME="RS11104ST-4B">4b</A>
Gregory RJH.
Chem. Rev.
1999,
99:
3649
<A NAME="RS11104ST-4C">4c</A>
North M.
Tetrahedron: Asymmetry
2003,
14:
147
<A NAME="RS11104ST-4D">4d</A>
Brunel J.-M.
Holmes IP.
Angew. Chem. Int. Ed.
2004,
43:
2752
For aluminum-catalyzed TMSCN enantioselective addition to aldehydes see:
<A NAME="RS11104ST-5A">5a</A>
Iovel I.
Popelis Y.
Fleisher M.
Lukevics E.
Tetrahedron: Asymmetry
1997,
8:
1279
<A NAME="RS11104ST-5B">5b</A>
Hamashima Y.
Sawada D.
Nogami H.
Kanai M.
Shibasaki M.
Tetrahedron
2001,
57:
805
<A NAME="RS11104ST-5C">5c</A>
Casas J.
Nájera C.
Sansano JM.
Saá JM.
Org. Lett.
2002,
4:
2589
<A NAME="RS11104ST-5D">5d</A> For aluminum-catalyzed TMSCN enantioselective addition to ketones see:
Deng H.
Isler MP.
Snapper ML.
Hoveyda AH.
Angew. Chem. Int. Ed.
2002,
41:
1009
<A NAME="RS11104ST-6">6</A>
Temperature of a cold room.
<A NAME="RS11104ST-7">7</A>
Typical Procedure
Catalysis Generation: A 2 M solution of trimethylalu-minum in toluene (25 µL, 0.05 mmol) was added dropwise
to a solution of ligand 1 (36 mg, 0.056 mmol) in 1.0 mL of chlorobenzene at r.t. After stirring for 30 min
at the same temperature, the resulting solution was cooled to 4 °C to be used as catalyst.
TMSCN Addition: Aldehyde 2 (0.5 mmol) was added in one portion to the catalyst solution at 4 °C and after 10
min TMSCN (73 µL, 0.55 mmol) was added over 2 min. The reaction mixture was stirred
at the same temperature for 24 h. Then the reaction was quenched with 2.0 mL of pH
7 buffer phosphate solution (Na2HPO4/NaH2PO4) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with
brine (5 mL), dried over MgSO4 and concentrated to give a colorless oil. The crude was purified by flash chromatography
on silica gel (petroleum ether-EtOAc, 5:1) to yield the corresponding silylated cyanohydrins.
<A NAME="RS11104ST-8A">8a</A>
Brusse J.
Roos EC.
Van der Gen A.
Tetrahedron Lett.
1988,
29:
4485
<A NAME="RS11104ST-8B">8b</A>
Almsick A.
Buddrus J.
Hoenicke-Schmidt P.
Laumen K.
Schneider M.
J. Chem. Soc., Chem. Commun.
1989,
18:
1391
<A NAME="RS11104ST-8C">8c</A>
Effenberger F.
Hörsch B.
Förster S.
Ziegler T.
Tetrahedron Lett.
1990,
31:
1249
<A NAME="RS11104ST-8D">8d</A>
Effenberg R.
Gutterer B.
Ziegler T.
Liebigs Ann. Chem.
1991,
269
<A NAME="RS11104ST-8E">8e</A>
Dhanoa D.
Bagley SW.
Chang RSL.
Lotti VJ.
Chen T.-B.
J. Med. Chem.
1993,
36:
3738
<A NAME="RS11104ST-8F">8f</A>
Effenberger F.
Eichhorn J.
Tetrahedron: Asymmetry
1997,
8:
469
<A NAME="RS11104ST-8G">8g</A>
Hwang CD.
Hwang D.-R.
Uang B.-J.
J. Org. Chem.
1998,
63:
6762
<A NAME="RS11104ST-8H">8h</A>
Yang WB.
Fang JM.
J. Org. Chem.
1998,
63:
1356
<A NAME="RS11104ST-8I">8i</A>
Abiko A.
Wang G.
Tetrahedron
1998,
54:
11405
<A NAME="RS11104ST-8J">8j</A>
Liang S.
Bu XR.
J. Org. Chem.
2002,
67:
2702
<A NAME="RS11104ST-8K">8k</A>
Nogami H.
Motomu K.
Shibasaki M.
Chem. Pharm. Bull.
2003,
51:
702
<A NAME="RS11104ST-9">9</A>
Characterization of the New Compounds:
Compound 3c: 1H NMR (300 MHz, CDCl3): δ = 7.32 (s, 2 H), 7.26 (s, 1 H), 5.66 (s, 1 H), 2.59 (s, 3 H), 0.48 (s, 9 H) ppm.
13C NMR (300 MHz, CDCl3): δ = 138.8, 136.2, 131.0, 124.2, 119.5, 63.8, 21.3, -0.1 ppm. IR (neat): 2960, 2921,
1612, 1464, 1255, 1159, 1101, 846, 754, 692 cm-1. Anal. Calcd for C13H19NOSi: C, 66.90; H, 8.21; N, 6.00. Found: C, 66.67; H, 7.95; N, 5.95. Enantiomer separation
by HPLC (Daicel Chiralpak AD, λ = 250 nm, heptane-i-PrOH = 99.95:0.05; 1.0 mL/min; 57% ee): t
R = 6.83 (major) and 7.98 min. [α]D -16.28 (c 2.12, CHCl3).
Compound 3f: 1H NMR (300 MHz, CDCl3): δ = 7.36 (m, 3 H), 5.43 (s, 1 H), 0.27 (s, 9 H) ppm. 13C NMR (300 MHz, CDCl3): δ = 139.5, 135.7, 129.6, 124.8, 118.3, 62.4, -0.2 ppm. IR (neat): 3083, 2961, 2901,
1592, 1574, 1435, 1259, 1202, 1119, 872, 805, 754 cm-1. Anal. Calcd for C11H13Cl2NOSi: C, 48.18; H, 4.78; N, 5.11. Found: C, 48.61; H, 5.17; N, 5.03. Enantiomer separation
by HPLC (Daicel Chiralpak AD, λ = 235 nm, heptane-i-PrOH = 99.5:0.5; 0.6 mL/min; 80% ee): t
R = 9.80 and 10.48 (major) min.
[α]D -12.52 (c 2.91, CHCl3).
Compound 3g: 1H NMR (300 MHz, CDCl3): δ = 7.69 (m, 1 H), 7.55 (m, 2 H), 5.43 (s, 1 H), 0.27 (s, 9 H) ppm. 13C NMR (300 MHz, CDCl3): δ = 139.9, 135.1, 128.1, 123.5, 118.2, 62.2, -0.2 ppm. IR (neat): 3076, 2959, 1589,
1562, 1427, 1256, 1193, 1118, 1095, 848, 742 cm-1. Anal. Calcd for C11H13Br2NOSi: C, 36.38; H, 3.61; N, 3.86. Found: C, 36.01; H, 2.99; N, 3.94. Enantiomer separation
by HPLC (Daicel Chiralcel OD, λ = 235 nm, heptane-i-PrOH = 99.8:0.2, 1.0 mL/min; 85% ee): t
R = 11.69 (major) and 16.01 min.
[α]D -9.39 (c 2.53, CHCl3).
Compound 3h: 1H NMR (300 MHz, CDCl3): δ = 7.49 (s, 1 H), 7.39-7.32 (m, 3 H), 5.45 (s, 1 H), 2.44 (t, J = 6.9 Hz, 2 H), 1.60-1.47 (m, 4 H), 0.98 (t, J = 6.9 Hz, 3 H) ppm. 13C NMR (300 MHz, CDCl3): δ = 136.4, 132.5, 129.5, 128.9, 125.4, 125.0, 119.0, 91.6, 79.9, 63.4, 30.8, 22.1,
19.1, 13.7, -0.2 ppm. IR (neat): 2959, 2934, 2873, 2230, 1603, 1482, 1431, 1330, 1256,
1108, 1082, 860, 848 cm-1. Anal. Calcd for C17H23NOSi: C, 71.53; H, 8.12; N, 4.91. Found: C, 70.98; H, 8.51; N, 5.05. Enantiomer separation
by HPLC (Daicel Chiralcel OD, λ = 250 nm, heptane-i-PrOH = 99.7:0.3; 1.0 mL/min; 82% ee): t
R = 18.16 (major) and 30.05 min. [α]D -9.11 (c 0.26, CHCl3).